OBI-866 ”Immunogenic/Therapeutic Glycan Compositions And Uses Thereof“ Was Granted By USPTO

1.Date of occurrence of the event:2022/12/23 2.Company name:OBI Pharma Inc. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios:Not applicable 5.Cause of occurrence: OBI Pharma Inc. was informed by the patent office that patent for OBI-866 ”Immunogenic/Therapeutic Glycan Compositions And Uses Thereof“ has been granted by United States Patent and […]